Loading stock data…
RMD
$195.96+2.82 (+1.46%)
Market OpenUpdated 3:40 PM EDT
ResMed Inc.
Historical Price
Price (Candle)
50-Day SMA
200-Day SMA
Whystock Brain
The Narrative
ResMed Inc. in the Healthcare sector is trading at $195.96. Wall Street consensus targets $270.60 (15 analysts), implying a +38.1% move over the next 12 months. The stock is currently near its 52-week low of $180.27, remaining 19.8% below its 200-day moving average. On fundamentals, Piotroski 7/9 indicates strong financial quality. The Whystock Score of 90/100 reflects bullish alignment across trend, valuation and analyst targets.
Ecosystem Influences
Sell-side targets imply +38.1% upside over 12 months
Long-term trend bearish (price vs 200-day SMA)
Macro-economic sensitivity to interest rate and inflation shifts
Loading Financials...
Peer Comparison
JNJUNHPFE
Whystock Valuation Model
Anchored to each ticker's own 5-year median trailing P/E, tilted by current ROE and growth. Fair P/E = own median P/E + (ROE × 10) + (max(revenue growth, earnings growth) × 15), capped at ±30% around the historical anchor. Fair Value = (Current Price ÷ Trailing P/E) × Fair P/E. Premium compounders like COST/MSFT are judged against their own multi-year norm rather than a sector median. Falls back to the sector-anchored formula (Tech ≈ 28, Comm Services ≈ 24, Utilities ≈ 18, Financials ≈ 14, etc.) for recent IPOs and tickers with insufficient history (< 24 monthly samples). Result is a normalised multiple gauge — not a price target.
Current Price$195.96
Potential Downside
0%
Whystock Fair Value$195.96
Price
UndervaluedFair ValueOvervalued
Simplified model based on P/E and ROE. Not a substitute for full valuation analysis. Data may be delayed. See our Terms.
Analyst Consensus15 analysts
Buy
Mean target$270.60+38.1%
Range$180.00 – $340.00
Fundamentals
ResMed Inc. develops, manufactures, distributes, and markets medical devices and cloud-based software applications to diagnose, treat, and manage respiratory disorders in the United States and internationally. The company operates in two segments, Sl...
Market Cap
Total dollar market value of a company's outstanding shares of stock (Price * Shares).
-
P/E Ratio
Priced for growth. Investors expect sustained double-digit expansion.
-
Beta
High-beta play. Expect amplified moves vs. the broad market.
-
Div Yield
Low to zero yield. Return is entirely dependent on price appreciation.
0.92%
ROE
Elite ROE. Management converts capital into profit efficiently.
23.41%
Volume
Today's trading volume
547,975
Recent News
Is This the Right Time to Retain Resmed Stock in Your Portfolio?
RMD gains from acquisition-led Residential Care Software growth, mask innovation and strong finances but faces macro and competitive pressures.
ResMed (RMD) Acquires Noctrix Health to Expand Sleep Disorder Portfolio
ResMed Inc. (NYSE:RMD) is one of the most undervalued large cap stocks to buy according to analysts. On June 1, ResMed finalized its acquisition of Noctrix Health, a medical device company known for developing non-pharmacologic wearable therapeutics. This strategic move expands ResMed’s clinical sleep health portfolio into the treatment of Restless Legs Syndrome/RLS, which is […]
ResMed completes $340m Noctrix Health acquisition
Noctrix Health’s lead product, Nidra, targets the peroneal nerves to address the symptoms of restless leg syndrome.
3 Big Reasons RMD Should Be On Your Watchlist
ResMed’s stock price has taken a beating over the past six months, shedding 26.3% of its value and falling to $185.29 per share. This may have investors wondering how to approach the situation.
Is It Time To Reassess ResMed (RMD) After A 25% Share Price Slide?
If you are wondering whether ResMed at around US$182.82 is pricing in too much optimism or not enough, you are in the right place to assess what that tag might actually represent. The stock has had a weaker run recently, with the share price down 12.1% over the past week, 10.8% over the past month, and 25.3% year to date, the same decline as over the past year. These moves sit against a backdrop of ongoing interest in sleep and respiratory care solutions and broader discussion around how...